Stock NANO NANOBIOTIX
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Nanobiotix

Equities

NANO

FR0011341205

Market Closed - Euronext Paris
Other stock markets
 11:35:02 2024-05-21 am EDT 		After market 02:12:31 pm
6.51 EUR -0.91% Intraday chart for Nanobiotix 6.515 +0.08%
May. 14 Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment MT
May. 14 Nanobiotix Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating Nbtxr3 for Patients with Stage Three Lung Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NANOBIOTIX Stock Nanobiotix
 336M -
MODERNA, INC. Stock Moderna, Inc.
 54.04B -
LONZA GROUP AG Stock Lonza Group AG
 41.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.92B
CELLTRION, INC. Stock Celltrion, Inc.
 28.35B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.35B
  1. Stock Market
  2. Equities
  3. NANO Stock
  4. Charts Nanobiotix
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW